Several risk scores for disease progression in Smoldering Multiple Myeloma (SMM) patients have been proposed, however, all have been developed using single center registries. To examine risk factors for time to progression (TTP) to Multiple Myeloma (MM) for SMM we analyzed a nationwide population-based cohort of 321 newly diagnosed SMM patients registered within the Danish Multiple Myeloma Registry between 2005 and 2014. Significant univariable risk factors for TTP were selected for multivariable Cox regression analyses. We found that both an M-protein ≥ 30g/l and immunoparesis significantly influenced TTP (HR 2.7, 95%CI(1.5;4.7), p=0.001, and HR 3.3, 95%CI(1.4;7.8), p=0.002 respectively). High free light chain (FLC) ratio did not significa...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
We explore the predictive role of 2014-updated International Myeloma Working Group (IMWG) diagnostic...
We explore the predictive role of 2014-updated International Myeloma Working Group (IMWG) diagnostic...
Agnieszka Blum, Despina Bazou, Peter O’Gorman Department of Hematology, Mater Misericordiae Un...
© The Author(s) 2020.Smoldering multiple myeloma (SMM) is an asymptomatic precursor state of multipl...
BACKGROUND: Smoldering multiple myeloma (SMM) presents a high risk of progression to symptomatic MM ...
Smoldering multiple myeloma (SMM) is an asymptomatic precursor state of multiple myeloma (MM). Recen...
Smoldering multiple myeloma (SMM) is an asymptomatic precursor state of multiple myeloma (MM). Recen...
BACKGROUND: Smoldering multiple myeloma (SMM) presents a high risk of progression to symptomatic MM ...
BACKGROUND: Smoldering multiple myeloma (SMM) presents a high risk of progression to symptomatic MM ...
Smoldering multiple myeloma is a heterogeneous asymptomatic precursor to multiple myeloma. Since its...
International audience: Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell diso...
International audience: Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell diso...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
We explore the predictive role of 2014-updated International Myeloma Working Group (IMWG) diagnostic...
We explore the predictive role of 2014-updated International Myeloma Working Group (IMWG) diagnostic...
Agnieszka Blum, Despina Bazou, Peter O’Gorman Department of Hematology, Mater Misericordiae Un...
© The Author(s) 2020.Smoldering multiple myeloma (SMM) is an asymptomatic precursor state of multipl...
BACKGROUND: Smoldering multiple myeloma (SMM) presents a high risk of progression to symptomatic MM ...
Smoldering multiple myeloma (SMM) is an asymptomatic precursor state of multiple myeloma (MM). Recen...
Smoldering multiple myeloma (SMM) is an asymptomatic precursor state of multiple myeloma (MM). Recen...
BACKGROUND: Smoldering multiple myeloma (SMM) presents a high risk of progression to symptomatic MM ...
BACKGROUND: Smoldering multiple myeloma (SMM) presents a high risk of progression to symptomatic MM ...
Smoldering multiple myeloma is a heterogeneous asymptomatic precursor to multiple myeloma. Since its...
International audience: Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell diso...
International audience: Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell diso...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...
Biomarkers reliably predicting progression to multiple myeloma (MM) are lacking. Myeloma risk has be...